Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA.
Institut für Philosophie, Literatur-, Wissenschafts- und Technikgeschichte, Fachgebiet Wissenschaftsgeschichte, Technische Universität Berlin, Germany.
Pharmacopsychiatry. 2021 Jul;54(4):151-166. doi: 10.1055/a-1310-3990. Epub 2020 Dec 7.
Initial interest in the value of psychedelic drugs ("psychotomimetics") in psychiatry began in the early 20 century, with explorations of the possibility that mescaline or peyote could produce psychosis-like effects. Over time, interest was focused on whether the effects of psychedelics could inform as to the underlying basis for psychiatric disorders. As research continued, and especially after the discovery of LSD in 1943, increasing interest in a role for psychedelics as adjuncts to psychotherapy began to evolve and became the major focus of work with psychedelics up to the present day.
早期对迷幻药物（“致幻剂”）在精神病学中的价值产生了初步兴趣，探索了麦司卡林或佩奥特碱是否可能产生类似精神病的效果。随着时间的推移，人们的兴趣集中在迷幻药的效果是否可以为精神疾病的潜在基础提供信息。随着研究的继续，特别是在 1943 年发现 LSD 之后，人们对迷幻剂作为心理治疗的辅助手段的作用越来越感兴趣，并逐渐成为迄今为止使用迷幻剂的主要工作重点。
